Related Experiment Video
Updated: Jun 21, 2026
08:50
Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets
Published on: July 3, 2018
[Relationship between glucose fluctuation and beta cell function in patients with diabetes]
1Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Yi Xue Za Zhi
|July 15, 2009
Summary
Glucose fluctuation significantly impairs beta cell function in diabetes mellitus patients, more so than sustained high blood sugar. This study highlights the impact of glycemic excursion on beta cell decline.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Research
Background:
- Beta cell dysfunction is central to diabetes mellitus (DM) pathogenesis.
- Understanding factors influencing beta cell function is crucial for managing DM.
- Glucose fluctuations, beyond average levels, may impact beta cell health.
Purpose of the Study:
- To investigate the relationship between glucose fluctuation and beta cell function in DM patients.
- To assess how glycemic variability (e.g., MAGE) correlates with beta cell function (e.g., DeltaCP).
Main Methods:
- Sixty hospitalized DM patients underwent continuous glucose monitoring (CGMS) and arginine stimulation tests.
- Measurements included fasting plasma glucose (FPG), HbA1c, mean glucose concentration (MBG), mean amplitude of glycemic excursion (MAGE), and incremental C-peptide (DeltaCP).
- Statistical analyses, including correlation and regression, were performed to determine relationships between glycemic parameters and beta cell function.
Main Results:
- Increasing HbA1c levels correlated with poorer glycemic profiles and higher FPG and postprandial glucose.
- Significant positive correlations were found between HbA1c, FPG, MBG, and MAGE.
- Beta cell function (DeltaCP) was negatively correlated with FPG, HbA1c, and MAGE, indicating impaired function with increased glucose variability.
- DeltaCP decreased significantly when HbA1c exceeded 7%.
Conclusions:
- Glucose fluctuation (MAGE) is a significant predictor of beta cell function decline in DM patients.
- Glycemic variability appears to be more detrimental to beta cell function than sustained hyperglycemia alone.
- Managing glucose fluctuations is essential for preserving beta cell function in diabetes management.
Related Concept Videos
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.